Pure Global

TOTAL HIP REPLACEMENT - FEMORAL STEM - India CDSCO Medical Device Registration

TOTAL HIP REPLACEMENT - FEMORAL STEM is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID MFG/MD/2019/000196_c40f70c8ecf0c20e121f582cbee06ff2_4caaeba0b446d4e8d65d06157aaa53c5. This device is marketed under the brand name SHARMA, SPCPL, DKSORTHO, DKSORTHO MEDICAL DEVICES, FINER. The license holder is DKSORTHO & SHARMA PHARMACEUTICAL PRIVATE LIMITED, and it is classified as Device Class Class D. The approving authority is Central Drug Standards Control Organization, Ahmedabad.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database
Powered by Pure Global AI
CDSCO Registered
Class Class D
TOTAL HIP REPLACEMENT - FEMORAL STEM
UID: MFG/MD/2019/000196_c40f70c8ecf0c20e121f582cbee06ff2_4caaeba0b446d4e8d65d06157aaa53c5

Brand Name

SHARMA, SPCPL, DKSORTHO, DKSORTHO MEDICAL DEVICES, FINER

Device Class

Class D

Approving Authority

Central Drug Standards Control Organization, Ahmedabad

Product Information

Total Hip Replacement (SHARMA, SPCPL, DKSORTHO, DKSORTHO MEDICAL DEVICES, FINER) isintended for use in the total hip arthroplasty and is intended for press fit (SHARMA, SPCPL, DKSORTHO, DKSORTHO MEDICAL DEVICES, FINER) use. Total hip arthroplasty is intended to provide increase patient mobility and reduce pain by replacing the damaged hip joint articulation in patients where there is evidence of sufficient sound bone to sit and support the components. Total hip replacement is indicated in the following conditions. a. Non-inflammatory degenerative joint disease including osteoarthritis, traumatic arthritis, rheumatoid arthritis or congenital hip dysplasia; and avascular necrosis. b. Correction of functional deformity. c. Treatment of non-union, femoral neck fracture, and trochanteric fractures of the proximal femur with head involvement, unmanageable by other techniques. d. Revision procedures where other treatment or devices have failed.

Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing